Clonidine extended-release tablets for pediatric patients with attention-deficit/hyperactivity disorder

Journal of the American Academy of Child and Adolescent Psychiatry

Volumn 50, Issue 2, 2011, Pages 171-179

  Jain, Rakesh ^a,b   Segal, Scott ^c   Kollins, Scott H ^d   Khayrallah, Moise ^e  

^a R/D Clinical Research Inc   (United States)

^b Texas Tech University Health Sciences Center at the Permian Basin   (United States)

^c Institute for Clinical Research   (United States)

^d DUKE UNIVERSITY   (United States)

^e Neuronex Inc   (United States)

Author keywords

2 adrenergic agonist; attention deficit hyperactivity disorder; clonidine hydrochloride extended release tablets

Indexed keywords

CLONIDINE; KAPVAY; UNCLASSIFIED DRUG;

ADOLESCENT; ARTICLE; ATTENTION DEFICIT DISORDER; BODY TEMPERATURE; CHILD; CLINICAL GLOBAL IMPRESSION SCALE; CONSTIPATION; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG DOSE ESCALATION; DRUG DOSE TITRATION; DRUG EFFICACY; DRUG SAFETY; ELECTROCARDIOGRAM; EMOTIONAL DISORDER; FATIGUE; FEMALE; HUMAN; IMPULSIVENESS; INSOMNIA; IRRITABILITY; MAJOR CLINICAL STUDY; MALE; NIGHTMARE; OTALGIA; OUTCOME ASSESSMENT; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RATING SCALE; SIDE EFFECT; SOMNOLENCE; XEROSTOMIA;

ADOLESCENT; ADRENERGIC ALPHA-2 RECEPTOR AGONISTS; ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY; CHILD; CLONIDINE; DELAYED-ACTION PREPARATIONS; DOUBLE-BLIND METHOD; DRUG TOXICITY; FEMALE; HUMANS; MALE;

EID: 78651479969     PISSN: 08908567     EISSN: 15275418     Source Type: Journal    
DOI: 10.1016/j.jaac.2010.11.005     Document Type: Article

References (38)

1. J.M. Halperin, J.H. Newcorn, and V. Sharma Inattentive and noninattentive ADHD children: do they constitute a unitary group? J Abnorm Child Psychol 18 1990 437 449
2. J.M. Halperin, K. Matier, G. Bedi, V. Sharma, and J.H. Newcorn Specificity of inattention, impulsivity, and hyperactivity to the diagnosis of attention-deficit hyperactivity disorder J Am Acad Child Adolesc Psychiatry 31 1992 190 196
3. W.J. Barbaresi, S.K. Katusic, R.C. Colligan, A.L. Weaver, and S.J. Jacobsen Long-term school outcomes for children with attention-deficit/ hyperactivity disorder: a population-based perspective J Dev Behav Pediatr 28 2007 265 273
4. S.P. Cuffe, C.G. Moore, and R. McKeown ADHD and health services utilization in the national health interview survey J Atten Disord 12 2009 330 340
5. S.V. Faraone, A.E. Doyle, E. Mick, and J. Biederman Meta-analysis of the association between the 7-repeat allele of the dopamine D(4) receptor gene and attention deficit hyperactivity disorder Am J Psychiatry 158 2001 1052 1057
6. L. Ben Amor, N. Grizenko, and G. Schwartz Perinatal complications in children with attention-deficit hyperactivity disorder and their unaffected siblings J Psychiatry Neurosci 30 2005 120 126
7. Bloom B, Cohen RA, Freeman G. Summary health statistics for U.S. children: National Health Interview Survey, 2007. Vital Health Stat 10. January 2009, no. 239, DHHS publication no (PHS) 2009-1567.
8. M. Dpfner, D. Breuer, N. Wille, M. Erhart, and U. Ravens-Sieberer How often do children meet ICD-10/DSM-IV criteria of attention deficit-/ hyperactivity disorder and hyperkinetic disorder? Parent-based prevalence rates in a national sampleresults of the BELLA study Eur Child Adolesc Psychiatry 17 suppl 1 2008 59 70
9. M. Huss, H. Holling, B.M. Kurth, and R. Schlack How often are German children and adolescents diagnosed with ADHD? Prevalence based on the judgment of health care professionals: results of the German health and examination survey (KiGGS) Eur Child Adolesc Psychiatry 17 suppl 1 2008 52 58
10. E.E. Nolan, K.D. Gadow, and J. Sprafkin Teacher reports of DSM-IV ADHD, ODD, and CD symptoms in schoolchildren J Am Acad Child Adolesc Psychiatry 40 2001 241 249
11. A.J. Arias, J. Gelernter, and G. Chan Correlates of co-occurring ADHD in drug-dependent subjects: prevalence and features of substance dependence and psychiatric disorders Addict Behav 33 2008 1199 1207
12. N.N. Rommelse, M.E. Altink, and E.A. Fliers Comorbid problems in ADHD: degree of association, shared endophenotypes, and formation of distinct subtypes Implications for a future DSM J Abnorm Child Psychol 37 2009 793 804
13. R.L. Findling Evolution of the treatment of attention-deficit/ hyperactivity disorder in children: a review Clin Ther 30 2008 942 957
14. W.J. Barbaresi, S.K. Katusic, R.C. Colligan, A.L. Weaver, C.L. Leibson, and S.J. Jacobsen Long-term stimulant medication treatment of attention-deficit/hyperactivity disorder: results from a population-based study J Dev Behav Pediatr 27 2006 1 10
15. A. Charach, A. Ickowicz, and R. Schachar Stimulant treatment over five years: adherence, effectiveness, and adverse effects J Am Acad Child Adolesc Psychiatry 43 2004 559 567
16. J.M. Swanson, G.R. Elliott, and L.L. Greenhill Effects of stimulant medication on growth rates across 3 years in the MTA follow-up J Am Acad Child Adolesc Psychiatry 46 2007 1015 1027
17. Treatment of ADHD in children with tics: a randomized controlled trial Neurology 58 2002 527 536
18. D.F. Connor, R.A. Barkley, and H.T. Davis A pilot study of methylphenidate, clonidine, or the combination in ADHD comorbid with aggressive oppositional defiant or conduct disorder Clin Pediatr (Phila) 39 2000 15 25
19. R.D. Hunt, R.B. Minderaa, and D.J. Cohen Clonidine benefits children with attention deficit disorder and hyperactivity: report of a double-blind placebo-crossover therapeutic trial J Am Acad Child Psychiatry 24 1985 617 629
20. V. Agarwal, P. Sitholey, S. Kumar, and M. Prasad Double-blind, placebo-controlled trial of clonidine in hyperactive children with mental retardation Ment Retard 39 2001 259 267
21. P.L. Hazell, and J.E. Stuart A randomized controlled trial of clonidine added to psychostimulant medication for hyperactive and aggressive children J Am Acad Child Adolesc Psychiatry 42 2003 886 894
22. V. Nair, and S. Mahadevan Randomised controlled study-efficacy of clonidine versus carbamazepine in children with ADHD J Trop Pediatr 55 2009 116 121
23. D.R. Palumbo, F.R. Sallee, W.E. Pelham Jr, O.G. Bukstein, W.B. Daviss, and M.P. McDermott Clonidine for attention-deficit/hyperactivity disorder: I Efficacy and tolerability outcomes J Am Acad Child Adolesc Psychiatry 47 2008 180 188
24. T.J. Schvehla, M.W. Mandoki, and G.S. Sumner Clonidine therapy for comorbid attention deficit hyperactivity disorder and conduct disorder: preliminary findings in a children's inpatient unit South Med J 87 1994 692 695
25. W.B. Daviss, N.C. Patel, and A.S. Robb Clonidine for attention-deficit/ hyperactivity disorder: II ECG changes and adverse events analysis J Am Acad Child Adolesc Psychiatry 47 2008 189 198
26. A. Kernen, S. Nyknen, and J. Taskinen Pharmacokinetics and side-effects of clonidine Eur J Clin Pharmacol 13 1978 97 101
27. A. Fujimura, A. Ebihara, and K. Ohashi Comparison of the pharmacokinetics, pharmacodynamics, and safety of oral (Catapres) and transdermal (M-5041T) clonidine in healthy subjects J Clin Pharmacol 34 1994 260 265
28. H. Groth, H. Vetter, and J. Knsel Clonidine through the skin in the treatment of essential hypertension: is it practical? J Hypertens Suppl 1 1983 120 122
29. Jain R, Kollins S, Bailey C, Holloway W, Horacek H, Khayrallah M. Developing a sustained release formulation of clonidine for the treatment of children and adolescents with attention deficit hyperactivity disorders (ADHD). Poster presented at: American College of Neuropsychopharmacology; December 7-11, 2008; Scottsdale, AZ.
30. United States Food and Drug Administration Statistical review and evaluation: clinical studies of Clonicel http://www.fda.gov/downloads/Drugs/ DevelopmentApprovalProcess/DevelopmentResources/UCM224108.pdf 2010 Accessed October 22, 2010
31. J. Biederman, R.D. Melmed, and A. Patel A randomized, double-blind, placebo-controlled study of guanfacine extended release in children and adolescents with attention-deficit/hyperactivity disorder Pediatrics 121 2008 e73 e84
32. F.R. Sallee, A. Lyne, T. Wigal, and J.J. McGough Long-term safety and efficacy of guanfacine extended release in children and adolescents with attention-deficit/hyperactivity disorder J Child Adolesc Psychopharmacol 19 2009 215 226
33. B.C. Strange Once-daily treatment of ADHD with guanfacine: patient implications Neuropsychiatr Dis Treat 4 2008 499 506
34. J. Biederman, J.M. Swanson, and S.B. Wigal Efficacy and safety of modafinil film-coated tablets in children and adolescents with attention-deficit/hyperactivity disorder: results of a randomized, double-blind, placebo-controlled, flexible-dose study Pediatrics 116 2005 e777 e784
35. D.K. Kelsey, C.R. Sumner, and C.D. Casat Once-daily atomoxetine treatment for children with attention-deficit/hyperactivity disorder, including an assessment of evening and morning behavior: a double-blind, placebo-controlled trial Pediatrics 114 2004 e1 e8
36. D. Michelson, A.J. Allen, and J. Busner Once-daily atomoxetine treatment for children and adolescents with attention deficit hyperactivity disorder: a randomized, placebo-controlled study Am J Psychiatry 159 2002 1896 1901
37. D. Michelson, D. Faries, and J. Wernicke Atomoxetine in the treatment of children and adolescents with attention-deficit/hyperactivity disorder: a randomized, placebo-controlled, dose-response study Pediatrics 108 2001 83
38. F.R. Sallee, J. McGough, T. Wigal, J. Donahue, A. Lyne, and J. Biederman Guanfacine extended release in children and adolescents with attention-deficit/hyperactivity disorder: a placebo-controlled trial J Am Acad Child Adolesc Psychiatry 48 2009 155 165